Nivolumab and ipilimumab for metastatic sarcoma

Self-reporting symptoms online improves patient care, chemotherapy duration and survival

Tivantinib as second line therapy for high-MET HCC

Pooled analysis of avelumab for metastatic urothelial carcinoma

Cancer and living meaningfully: the CALM intervention

'Conquer Fear' of disease recurrence

Larotrectinib shows durable efficacy across diverse paediatric and adult cancers

Routine genomic testing is feasible, but only a subset of patients benefit

Molecular profiles and the future of adjuvant therapy

Pregnancy after breast cancer no associated with relapse risk

Delaying metastatic prostate cancer, improving survival with abiraterone

Hypogonadism following cisplatin treatment of testicular cancer